Cognyte Software (NASDAQ:CGNT – Get Free Report) released its quarterly earnings data on Tuesday. The medical device company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.07, Briefing.com reports. Cognyte Software had a negative return on equity of 5.94% and a negative net margin of 3.70%. The business had revenue of $84.40 million for the quarter, compared to analysts’ expectations of $83.69 million. During the same period in the previous year, the business posted ($0.11) earnings per share. Cognyte Software’s quarterly revenue was up 9.5% on a year-over-year basis. Cognyte Software updated its FY 2025 guidance to -0.030–0.030 EPS and its FY25 guidance to $(0.03) EPS.
Cognyte Software Stock Down 13.0 %
Shares of CGNT stock opened at $6.47 on Wednesday. The company has a market capitalization of $465.13 million, a P/E ratio of -38.06 and a beta of 1.74. The firm has a 50-day moving average price of $7.46 and a 200 day moving average price of $7.51. Cognyte Software has a 12-month low of $4.00 and a 12-month high of $8.70.
Analyst Ratings Changes
Several analysts have recently weighed in on CGNT shares. Needham & Company LLC reiterated a “hold” rating on shares of Cognyte Software in a research report on Tuesday. StockNews.com raised Cognyte Software from a “buy” rating to a “strong-buy” rating in a report on Friday, June 21st. Finally, Wedbush increased their target price on Cognyte Software from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Thursday, June 20th.
About Cognyte Software
Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company offers network intelligence analytics, threat intelligence analytics, decision intelligence analytics, and operational intelligence analytics solutions.
Featured Stories
- Five stocks we like better than Cognyte Software
- What is the Dogs of the Dow Strategy? Overview and Examples
- Is Redfin Stock a Buy? Housing Market Recovery Could Fuel Upside
- How to Capture the Benefits of Dividend Increases
- An EV OEM Shakeout Is Underway: Who Will Win?
- 3 Small Caps With Big Return Potential
- Why Hedge Funds Are Betting Big on Alibaba and Baidu for 2024
Receive News & Ratings for Cognyte Software Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognyte Software and related companies with MarketBeat.com's FREE daily email newsletter.